Nitazenes

nitazenes

Last published: October 05, 2026

What are nitazenes?

Nitazenes are potent synthetic opioids. 

Opioids include any drug that acts on the opioid receptors in the brain and body, and any natural or synthetic (lab-made) drug that is made from, or related to, the opium poppy plant.1

Nitazenes are also known as new/novel psychoactive substances (NPS). This is a broad term for drugs that are not well studied and have little to no history of widespread use in the community, or in medical settings.2, 3

Nitazenes were developed by researchers around 60 years ago as an alternative to morphine, but because of their high potential for overdose were never released.4

Nitazenes have been connected to a number of overdose deaths worldwide.5

What do nitazenes look like?

Nitazenes are sold as a white powder, crystalline solid, or brown/yellow powder. They have also been found in tablets (fake oxycodone), heroin, ketamine, and synthetic cannabinoids.4, 6

Other names

benzimidazole opioids, synthetic opioids, New Psychoactive Substances (NPS)

Some common nitazenes include:

  • isotonitazene
  • metonitazene
  • etonitazene
  • protonitazene.

Effects of nitazenes

There is no safe level of drug use. Use of any drug always carries some risk. It’s important to be careful when taking any type of drug. 

Nitazenes affect everyone differently, based on:

  • size, weight and health
  • whether the person is used to taking it
  • whether other drugs are taken around the same time
  • the amount taken
  • the strength of the drug (varies from batch to batch).

Onset and duration of effects

How fast a drug takes effect and how long it lasts can vary depending on how it's taken - for example, whether it's snorted, swallowed, or injected.7

There are many types of nitazenes, and research on them is limited. How quickly their effects are felt, and how long they last, can vary between types.8

Effects

Effects can include:

  • euphoria 
  • relaxation, drowsiness and clumsiness
  • pain relief
  • reduced stress 
  • itchiness 
  • nausea and vomiting 
  • fever and sweating 
  • slow breathing and heart rate.9

Impact of mood and environment

Drugs that affect a person’s mental state (psychoactive drugs) can also have varied effects depending on a person’s mood (often called the ‘set’) or the environment they are in (the ‘setting’): 

  • Set: a person’s state of mind, previous encounters with the drug, and expectations of what’s going to happen. For example, feelings of stress or anxiety before using nitazenes may result in an unpleasant experience and make those feelings worse.
  • Setting: the physical and social environment where you take nitazenes – whether it’s known and familiar, who you're with, if you're indoors or outdoors, the type of music or sounds, and lighting. The ideal setting to take nitazenes will vary based on the individual and drug they’re using.10

Being in a good state of mind, with trusted friends and a safe environment before taking nitazenes reduces the risk of having a bad experience.10

Overdose

If you take a large amount of nitazenes or use a strong batch, you could overdose.5

The potency (strength) of nitazenes varies between drugs in the class. They can range from levels similar to morphine, to a lot stronger than fentanyl.11, 12

Your risk of overdose can also increase if you mix nitazenes with alcohol or other drugs, including medications.

Nitazene overdose can cause death.5

Call triple zero (000) and request an ambulance if you or someone else has any of the following symptoms (emergency services are there to help and can provide more instructions).

Signs of opioid overdose can include:

  • unconscious or non-responsive
  • slow breathing, abnormal breathing, or not breathing at all
  • slow or no heartbeat and pulse
  • choking or gurgling sounds
  • skin colour changes, especially lips and fingernails
  • bluish-purple skin for people with lighter complexions
  • greyish or ashen skin for people with darker complexions
  • vomiting
  • cool or clammy (wet and sweaty) skin
  • small ‘pinpoint’ pupils.13, 14

Learn more on overdose and drug-related emergencies.

Naloxone

Naloxone (also known as Nyxoid®/Narcan®) temporarily reverses the effects of opioid overdose (including nitazenes). It’s available for free over the counter from most local pharmacies and can be administered by anyone, including family or friends and bystanders.15

If a person does not respond to the first dose after 3 minutes, give them a second dose. This can be repeated until the ambulance arrives.16, 17

Find naloxone near you

Mixing with other drugs

Mixing nitazenes with other drugs can have unpredictable effects and increase the risk of harm.

Mixing includes using more than one drug (including alcohol or medications) at the same time, or one after another. You should also consider what drugs you’ve taken in the last 24 hours.

Due to the lack of formal research around mixing nitazenes with other substances, this information covers mixing other drugs with opioids: 

Low risk

  • Opioids and cannabis: can work together to increase the effects of both drugs, there is a risk of being more impaired than wanted or planned.

Caution required 

  • Opioids and MDMA/LSD: Unlikely to cause interaction. Don’t use Tramadol and MDMA together due to risk of seizures.

Dangerous

  • Opioids and nitrous oxide: Can cause impaired coordination, memory loss and passing out.
  • Opioids and GHB/GBL/benzodiazepines/alcohol: Can cause difficulty breathing, passing out, vomiting and possible death. 
  • Opioids and ketamine: Can cause nausea, vomiting, passing out, and possible death.
  • Opioids and cocaine/crystal methamphetamine (ice)/amphetamines: Increases the risk of heart strain. The stimulant effect of these drugs increases heart rate, and the opioid decreases heart rate. Depending on the amount taken there is a risk of respiratory arrest or heart problems if one wears off before the other.18-20

Using more than one drug or type of drug at the same time is called polydrug use.14

More on Polydrug use

Polydrug use is a term for the use of more than one drug or type of drug at the same time or one after another. Polydrug use can involve both illicit drugs and legal substances, such as alcohol and medications.

READ MORE

Reducing harm

There are ways you can reduce the risk of harm when using nitazenes.

  • Start low, go slow – try a little bit first to see how you feel. Wait at least 5 hours before deciding whether to take more.
  • Keep naloxone nearby – in case of an overdose.
  • Test your drugs if there is an available drug checking (pill testing) service near you, to find out what the drugs contain and how strong they are.
  • Never use alone – use around people you trust and somewhere you feel safe. If you are using with someone else, use at separate times.
  • Don’t operate machinery, drive, or swim.15, 21-23

If injecting

  • Always use new needles – never share needles or other injecting equipment. Use your own spoon/cup and tourniquet. Use new barrels, filters, sterile water, and swabs. Safely dispose of used equipment.
  • Visit a needle and syringe program for sterile equipment, disposal of used equipment, and expert medical advice.15, 21-23

Coming down

Nitazenes are not known to cause comedown effects.

Long-term effects

Long-term effects can vary depending on how much, how often and how nitazenes are consumed.

The long-term effects of nitazenes haven’t been studied enough to understand what the risks might be, but it’s thought they may be like other opioids, such as fentanyl.24

Some common long-term effects of opioids include:

  • constipation
  • increased risk of getting sick from viruses and infections
  • sleep problems
  • reduced bone density and higher risk of breaking bones
  • heightened sensitivity to pain (opioid-induced hyperalgesia)
  • impacts on hormone levels leading to reduced sex drive, infertility, erectile dysfunction, or menstrual cycle changes.25, 26

Nitazenes and mental health

Research has found a link between some mental health conditions and the risk of opioid overdose.27, 28

There is evidence that as many as 1 in 3 people with an opioid use disorder also have post-traumatic stress disorder (PTSD).29

People experiencing mental health concerns such as depression, anxiety, PTSD, psychosis, or bipolar disorder are also more likely to experience an opioid overdose compared to those without these conditions.27

This association has been seen across different groups, including people in emergency departments, veterans, and those in prison settings.27

Tolerance

Regularly taking nitazenes can lead to developing a tolerance, which means you need to take larger amounts to get the same effects.30

Tolerance to nitazenes also affects other opioids (known as cross-tolerance). For example, tolerance to nitazenes will also result in a higher tolerance to oxycodone or fentanyl.20, 31

Tolerance should return to normal within 1 – 2 weeks of not using opioids.20

Dependence

People who regularly use nitazenes may become dependent. They may feel they need to use nitazenes to go about usual activities like working, studying and socialising, or just to get through the day.30, 32

Withdrawal

Withdrawal refers to the symptoms that can occur when someone who is dependent on a drug, or who has been using it regularly over time, stops or reduces their use.33

Withdrawal can include physical symptoms (such as headaches, or nausea) and psychological symptoms (such as anxiety, or depressed mood).33

Symptoms - including how strong they are and how long they last - will vary depending on the type of drug and a person’s history of use.33

Withdrawal from nitazenes can be potentially life-threatening.34

If you, or someone you care about, is planning to stop taking nitazenes after using them for a long time, it’s important to speak with a medical professional for guidance and supervision.

Withdrawal symptoms

Reducing, or stopping using nitazenes after a period of regular use can lead to withdrawal symptoms, including:

  • excessive sweating 
  • restless legs 
  • fever 
  • dizziness
  • flu-like symptoms
  • blackouts
  • anxiety 
  • panic attacks.35, 36

Reduced tolerance and overdose risk

After withdrawing from opioids such as nitazenes, your body is no longer used to it and your tolerance drops.20

This means if you use the same amount as before, it can be too much for your body and cause an overdose.20

Always start with a lower dose after a break from nitazenes or other opioid drugs.20

Pregnancy and breastfeeding

Before pregnancy

There is research that shows opioid drugs, including nitazenes, can impact fertility.

They can:

  • affect menstrual cycles
  • lower sex drive.
  • lower testosterone levels
  • reduce sperm quality and movement
  • cause erectile dysfunction.37-39

During pregnancy

Opioid use during pregnancy can harm the baby’s development.40, 41

Opioids can pass to your baby via the placenta. This can affect the baby’s growth and result in a premature (early) birth, which has other health impacts on the baby.40

Other chemicals may be present in illegal or counterfeit (fake) opioid medication, and there is no way to know exactly how these will impact the baby or the pregnancy.42

If you’re injecting opioids, it’s important to not share injecting equipment with other people. This protects you and the baby from bloodborne viruses such as HIV and hepatitis C.43

After pregnancy

Opioid use during pregnancy can sometimes cause withdrawal symptoms in babies after birth. This is known as neonatal opioid withdrawal syndrome (NOWS).41, 44

NOWS is easily diagnosed and treated, and not all babies will experience symptoms.44

Breastfeeding your baby while using opioids in high doses is not recommended, as the drugs can be present in breastmilk and affect the baby.40, 43, 45, 46

If you’re planning to breastfeed, make sure you talk with your midwife or doctor about your use of opioids.41

Getting help

If your use of nitazenes is affecting your health, family, relationships, work, school, financial or other life situations, or you’re concerned about someone, there is help and support. 

Path2Help

Not sure what you are looking for?
Try our intuitive Path2Help tool and be matched with support information and services tailored to you.

Find out more
Image of a woman walking through a maze

Nitazenes are considered new/novel psychoactive substances (NPS) and the laws surrounding NPS are complex, constantly changing and differ between states/territories, but in general they are increasingly becoming stronger.

In Queensland, New South Wales, South Australia and Victoria there is now a ‘blanket ban’ on possessing or selling any substance that has a psychoactive effect other than alcohol, tobacco and food.

In other states and territories in Australia, specific NPS substances are banned and new ones are regularly added to the list. This means that a drug that was legal to sell or possess today, may be illegal tomorrow. The substances banned differ between these states/territories.

National

Nitazenes have been detected at drug checking services in Canberra, Queensland and Victoria. In these cases, nitazenes were unexpectedly found in drug samples thought to contain other drugs, such as heroin or oxycodone.47, 48

Since 2021, at least 17 overdose deaths related to nitazenes have been reported in Australia.5


  1. Wexler B. Opioids. Gale Health and Wellness Online Collection [e-book]. Farmington Hills, MI: Gale, 2022 [cited 2026 Sep 9]. Available from:
  2. Potter GR, Chatwin C. Not particularly special: critiquing ‘NPS’ as a category of drugs. Drugs: Education, Prevention and Policy [Internet]. 2018. [cited 2026 Aug 26];25(4):329–36.
  3. King LA, Kicman AT. A brief history of 'new psychoactive substances'. Drug testing and analysis [Internet]. 2011. [cited 2026 Aug 26];3(7-8):401–3.
  4. World Health Organization. Critical review report: Protonitazene draft. [Internet]. 2022. [cited 2025 Nov 12] p. 
  5. Darke S, Duflou J, Farrell M, Lappin J, Peacock A. Emergence of deaths due to nitazene toxicity in Australia. Drug and Alcohol Review [Internet]. 2024. [cited 2026 Sep 10];43(7):2093–4.
  6. FRANK. Synthetic Opioids. n.d. [cited 2026 Sep 30]
  7. Psychonaut Wiki. Routes of administration. 2026. [cited 2026 Sep 8]
  8. National Drug & Alcohol Research Centre (NDARC). NDARC fact sheet: Nitazenes. 2025. [cited 2026 Oct 1]
  9. High Alert. What are nitazenes? [Internet]. 2024. [cited 2026 Sep 28]
  10. Nutt D. Drugs without the hot air : making sense of legal and illegal drugs [e-book]. 2nd ed. Cambridge: UIT Cambridge Ltd; 2020
  11. Roberts A, Korona-Bailey J, Mukhopadhyay S. Notes from the Field: Nitazene-Related Deaths — Tennessee, 2019–2021. Morbidity and Mortality Weekly Report (MMWR) [Internet]. 2022. [cited 31.05.2023]
  12. NSW Health. Warning issued after potent opioid (nitazene) found in heroin. [Internet]. 2022. [cited 06.06.2023]
  13. Schuckit MA. Drug and alcohol abuse : a clinical guide to diagnosis and treatment [e-book]. 6th ed.: Springer; 2006 [cited 2025 Feb 13].
  14. Darke S, Lappin J, Farrell M. The clinician's guide to illicit drugs and health [e-book]. Silverback Publishing; 2019
  15. Australian Government Department of Health and Aged Care. About the Take Home Naloxone program. 2024. [cited 2026 Sep 30]
  16. Nyxoid. Australian Product Information - Nyxoid® (Naloxone Hydrochloride Dihydrate) Nasal Spray). 2022. [cited 2026 Sep 30]
  17. Harm Reduction Victoria. 5 Steps To Life. Reverse Opioid Overdose. [cited 2026 Sep 30]
  18. Hi-Ground. Opioids. n.d. [cited 2026 Sep 11]
  19. Harm Reduction Victoria. Opioids. n.d. [cited 2026 Sep 30]
  20. Psychonaut Wiki. Opioids. 2022. [cited 2026 Sep 9]
  21. Nyxoid. Australian Product Information - Nyxoid® (NALOXONE HYDROCHLORIDE DIHYDRATE) NASAL SPRAY. [Internet]. 2022. [cited 18.09.2024]:7.
  22. Maghsoudi N, Tanguay J, Scarfone K, Rammohan I, Ziegler C, Werb D, et al. Drug checking services for people who use drugs: a systematic review. Addiction [Internet]. 2022. [cited 18.11.2025];117(3):532–44.
  23. Giulini F, Keenan E, Killeen N, Ivers J-H. A Systematized Review of Drug-checking and Related Considerations for Implementation as A Harm Reduction Intervention. Journal of Psychoactive Drugs [Internet]. 2023. [cited 2026 Sep 4];55(1):85–93.
  24. Pergolizzi J, Raffa R, LeQuang JAK, Breve F, Varrassi G. Old Drugs and New Challenges: A Narrative Review of Nitazenes. Cureus [Internet]. 2023. [cited 2026 Sep 30];15(6):e40736.
  25. Kotlińska-Lemieszek A, Żylicz Z. Less Well-Known Consequences of the Long-Term Use of Opioid Analgesics: A Comprehensive Literature Review. Drug design, development and therapy [Internet]. 2022. [cited 2026 Sep 30];16:251–64.
  26. Australian Commission on Safety and Quality in Health Care. Abstral. 2021. [cited 2026 Sep 30]
  27. van Draanen J, Tsang C, Mitra S, Phuong V, Murakami A, Karamouzian M, et al. Mental disorder and opioid overdose: a systematic review. Social Psychiatry and Psychiatric Epidemiology : The International Journal for Research in Social and Genetic Epidemiology and Mental Health Services [Internet]. 2021. [cited 2025 Oct 09];57(4):647–71.
  28. Bohnert ASB, Ilgen MA. Understanding Links among Opioid Use, Overdose, and Suicide. New England Journal of Medicine [Internet]. 2019. [cited 2025 Oct 16];380(14):1379–80.
  29. Mills KL, Teesson M, Ross J, Peters L. Trauma, PTSD, and substance use disorders: findings from the Australian National Survey of Mental Health and Well-Being. The American journal of psychiatry [Internet]. 2006. [cited 2025 Oct 16];163(4):652–8.
  30. John Hopkins Medical. What are opioids? n.d. [cited 2026 Sep 11]
  31. Pasternak GW. Chapter 31 - Opioids. In: Hemmings HC, Hopkins PM, editors. Foundations of Anesthesia (Second Edition) [e-book]. Edinburgh: Mosby, 2006 [cited 2026 Sep 14]; 373–83.
  32. Drug Enforcement Administration Diversion Control Division Drug & Chemical Evaluation Section. Benzimidazole-Opioids Other Name: Nitazenes. 2022. [cited 2026 Sep 30]
  33. NSW Ministry of Health. Management of Withdrawal from Alcohol and Other Drugs Clinical Guidance. [Internet]. St Leonards, NSW: NSW Health. 2022. [cited 2026 Sep 3] p. 
  34. Darke S, Larney S, Farrell M. Yes, people can die from opiate withdrawal. Addiction [Internet]. 2017. [cited 2026 Sep 11];112(2):199–200.
  35. World Health Organization. Critical review report: Etonitazepyne (N-pyrrolidinoetonitazene). [Internet]. [cited 08.06.2023] p. 
  36. Advisory Council on the Misuse of Drugs. ACMD advice on 2-benzyl benzimidazole and piperidine benzimidazolone opioids. 2026. [cited 2026 Sep 30]
  37. Lo JO, Hedges JC, Chou WH, Tager KR, Bachli ID, Hagen OL, et al. Influence of substance use on male reproductive health and offspring outcomes. Nature reviews Urology [Internet]. 2024. [cited 2025 Nov 07];21(9):534–64.
  38. Zhao S, Deng T, Luo L, Wang J, Li E, Liu L, et al. Association Between Opioid Use and Risk of Erectile Dysfunction: A Systematic Review and Meta-Analysis. [Internet]. 2017. [cited 2025 Nov 07];14(10):1209–19.
  39. Safarinejad MR, Asgari SA, Farshi A, Ghaedi G, Kolahi AA, Iravani S, et al. The effects of opiate consumption on serum reproductive hormone levels, sperm parameters, seminal plasma antioxidant capacity and sperm DNA integrity. Reproductive Toxicology [Internet]. 2013. [cited 2025 Nov 07];36:18–23.
  40. Corsi DJ, Murphy MSQ. The Effects of opioids on female fertility, pregnancy and the breastfeeding mother-infant dyad: A Review. Basic & Clinical Pharmacology & Toxicology [Internet]. 2021. [cited 2026 Aug 24];128(5):635–41.
  41. Centre for Alcohol and Other Drugs. Clinical Guidance for the Management of Substance Use in Pregnancy, Birth and the Postnatal Period. [Internet]. Sydney,: NSW Health; 2024. [cited 2026 Sep 9]
  42. National Harm Reduction Coalition. Fentanyl Use and Overdose Prevention Tips. 2024. [cited 2026 Aug 25]
  43. The Royal Women's Hospital. Using heroin during pregnancy and breastfeeding 2021. [cited 2026 Sep 30]
  44. The Royal Women's Hospital. Using prescription opioids during pregnancy and breastfeeding. 2021. [cited 2026 Aug 24]
  45. Ito S. Opioids in Breast Milk: Pharmacokinetic Principles and Clinical Implications. Journal of clinical pharmacology [Internet]. 2018. [cited 2026 Aug 24];58 Suppl 10:S151–S63.
  46. Bogen DL, Whalen BL. Breastmilk feeding for mothers and infants with opioid exposure: What is best? Seminars in Fetal and Neonatal Medicine [Internet]. 2019. [cited 2026 Aug 24];24(2):95–104.
  47. Australian Institute of Health and Welfare. Alcohol, tobacco & other drugs in Australia - New psychoactive substances. Australian Government; 2026. [cited 2026 Sep 10]
  48. The Know. Search results for "nitazene". n.d. [cited 2026 Sep 10]

Explore opioids on the Drug Wheel

Drug wheel segment - Opioids segment@2x.png

Effects

coma , death , euphoria , itching , nausea , passing out , relaxation , shallow breathing